Intensity Therapeutics, Inc. (INTS) SEC Filings — 2024
17 SEC filings for Intensity Therapeutics, Inc. (INTS) in 2024.
Filings
- Intensity Therapeutics Files S-1 for Potential Securities Offering — S-1 · Dec 13, 2024
- Intensity Therapeutics Enters Material Definitive Agreement — 8-K · Nov 22, 2024
- Intensity Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Intensity Therapeutics Appoints New Chief Medical Officer — 8-K · Oct 23, 2024
- Intensity Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Intensity Therapeutics Files 8-K on Officer Changes and Shareholder Votes — 8-K · Jul 17, 2024
- Intensity Therapeutics Files 8-K — 8-K · Jul 3, 2024
- Intensity Therapeutics, Inc. SC 13G Filing — SC 13G · Jun 7, 2024
- Intensity Therapeutics Files Definitive Proxy Statement — DEF 14A · Jun 4, 2024
- Intensity Therapeutics Appoints New Director, Loses One — 8-K · May 24, 2024
- Intensity Therapeutics Appoints New Chief Medical Officer — 8-K · May 15, 2024
- Intensity Therapeutics Enters Material Definitive Agreement — 8-K · May 10, 2024
- INTENSITY THERAPEUTICS, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Intensity Therapeutics Faces Delisting Concerns — 8-K · Apr 19, 2024
- INTENSITY THERAPEUTICS, INC. Files 2023 Annual Report on Form 10-K — 10-K · Mar 14, 2024
- Intensity Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 13, 2024
- Intensity Therapeutics 8-K: Officer/Director Changes, Comp Arrangements — 8-K · Feb 7, 2024